CDXS - Codexis, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Codexis, Inc.

200 Penobscot Drive
Redwood City, CA 94063
United States
650-421-8100
http://www.codexis.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees116

Key Executives

NameTitlePayExercisedYear Born
Mr. John J. NicolsPres, CEO & Director1.11MN/A1964
Mr. Gordon T. B. SangsterSr. VP & CFO598.87kN/A1953
Dr. James J. LalondeSr. VP of R&D506.21k14.33k1961
Mr. Achilles Antonio ClementDirector of Latin AmericaN/AN/AN/A
Ms. Shawn ClairmontSr. Director of Molecular DiagnosticsN/AN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Codexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

Corporate Governance

Codexis, Inc.’s ISS Governance QualityScore as of November 1, 2018 is 5. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.